EYPT:NASDAQ
EyePoint Inc
$3.85
arrow_downward
-3.51%(-0.14) 1D
$3.90
arrow_upward
+1.30% (+0.050)bedtimeAfter hours
Closed: Sep 18, 4:00:02 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
$3.95
High
$4.06
Low
$3.77
Mkt. cap
331.92M
Avg. vol.
5.84M
Volume
7.27M
52-wk high
$19.01
52-wk low
$3.42
EPS
-$3.74
Beta
1.63
Shares outstanding
86.21M
No. of employees
214
Open
$3.95
High
$4.06
Low
$3.77
Mkt. cap
331.92M
Avg. vol.
5.84M
Volume
7.27M
52-wk high
$19.01
52-wk low
$3.42
EPS
-$3.74
Beta
1.63
Shares outstanding
86.21M
No. of employees
214
News stories
From web sources and news partners
Benzinga
·
2 days ago
Xenon Pharmaceuticals, Steel Dynamics, Nucor And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
CarePlus VietNam
·
1 month ago
EyePoint Inc. (EYPT) Gains 2.76% as Stock Approaches Key Resistance Level - Stop Hunt
CarePlus VietNam
·
1 month ago
EyePoint Inc. (EYPT) Slips 2.25% but Holds Above Key Support as Sector Uncertainty Persists - Chandelier Stop
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. In December 2025, the company changed its corporate name to EyePoint, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersWatertown, Massachusetts, United States
SectorPharmaceutical industry
Websiteeyepoint.bio